TL;DR
Children with achondroplasia, the most common form of dwarfism, grow slowly because a signal at the ends of their bones is stuck on "brake," and a drug made to release it is a shot given every day. Europe's medicines regulators have now backed a version given once a week, and its maker is lining up a first European launch. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.
Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.



